287 related articles for article (PubMed ID: 22801794)
1. Prognostic factors of paraneoplastic pemphigus.
Leger S; Picard D; Ingen-Housz-Oro S; Arnault JP; Aubin F; Carsuzaa F; Chaumentin G; Chevrant-Breton J; Chosidow O; Crickx B; D'incan M; Dandurand M; Debarbieux S; Delaporte E; Dereure O; Doutre MS; Guillet G; Jullien D; Kupfer I; Lacour JP; Leonard F; Lok C; Machet L; Martin L; Paul C; Pignon JM; Robert C; Thomas L; Weiller PJ; Ferranti V; Gilbert D; Courville P; Houivet E; Benichou J; Joly P
Arch Dermatol; 2012 Oct; 148(10):1165-72. PubMed ID: 22801794
[TBL] [Abstract][Full Text] [Related]
2. Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients.
Zhang B; Zheng R; Wang J; Bu D; Zhu X
J Invest Dermatol; 2006 Apr; 126(4):832-40. PubMed ID: 16470171
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus.
Wang J; Bu DF; Li T; Zheng R; Zhang BX; Chen XX; Zhu XJ
Br J Dermatol; 2005 Sep; 153(3):558-64. PubMed ID: 16120143
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of 12 Korean patients with paraneoplastic pemphigus.
Choi Y; Nam KH; Lee JB; Lee JY; Ihm CW; Lee SE; Oh SH; Hashimoto T; Kim SC
J Dermatol; 2012 Dec; 39(12):973-81. PubMed ID: 22938021
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic pemphigus.
Yong AA; Tey HL
Australas J Dermatol; 2013 Nov; 54(4):241-50. PubMed ID: 22759072
[TBL] [Abstract][Full Text] [Related]
6. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.
Nguyen VT; Ndoye A; Bassler KD; Shultz LD; Shields MC; Ruben BS; Webber RJ; Pittelkow MR; Lynch PJ; Grando SA
Arch Dermatol; 2001 Feb; 137(2):193-206. PubMed ID: 11176692
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic pemphigus. Induction of autoantibodies against structural proteins in the skin].
Zillikens D; Bröcker EB
Hautarzt; 1994 Dec; 45(12):827-33. PubMed ID: 7843961
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic pemphigus in children and adolescents.
Mimouni D; Anhalt GJ; Lazarova Z; Aho S; Kazerounian S; Kouba DJ; Mascaro JM; Nousari HC
Br J Dermatol; 2002 Oct; 147(4):725-32. PubMed ID: 12366419
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of inflammatory infiltrates in lesions of the oral mucosa, skin, and bronchioles in a case of paraneoplastic pemphigus.
Iida K; Yamaguchi F; Hibi K; Tate G; Ohyama B; Numata S; Hashimoto T; Sato M; Uchida T; Sueki H
Eur J Dermatol; 2012; 22(1):154-5. PubMed ID: 22370168
[No Abstract] [Full Text] [Related]
10. Extremities of the N-terminus of envoplakin and C-terminus of its linker subdomain are major epitopes of paraneoplastic pemphigus.
Wang X; Chen T; Zhao J; Peng Y; Chen X; Tu P; Zhu X; Liu Z; Wang M
J Dermatol Sci; 2016 Oct; 84(1):24-29. PubMed ID: 27427435
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and intractable mucosal erosions: Treatment with cyclosporin in addition to steroid, rituximab and intravenous immunoglobulin.
Namba C; Tohyama M; Hanakawa Y; Murakami M; Shirakata Y; Matsumoto T; Suemori K; Ishii N; Hashimoto T; Sayama K
J Dermatol; 2016 Apr; 43(4):419-22. PubMed ID: 26506947
[TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic pemphigus: Retrospective study of a case series].
Fournet M; Roblot P; P Levillain ; Guillet G; Machet L; Misery L
Ann Dermatol Venereol; 2018 Oct; 145(10):564-571. PubMed ID: 30126641
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids.
Almugairen N; Hospital V; Bedane C; Duvert-Lehembre S; Picard D; Tronquoy AF; Houivet E; D'incan M; Joly P
J Am Acad Dermatol; 2013 Oct; 69(4):583-8. PubMed ID: 23850258
[TBL] [Abstract][Full Text] [Related]
14. Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.
Li J; Bu DF; Huang YC; Zhu XJ
Chin Med J (Engl); 2009 Mar; 122(5):486-95. PubMed ID: 19323896
[TBL] [Abstract][Full Text] [Related]
15. Fatal paraneoplastic pemphigus after removal of Castleman's disease in a child.
Daneshpazhooh M; Moeineddin F; Kiani A; Naraghi ZS; Firooz A; Akhyani M; Chams-Davatchi C
Pediatr Dermatol; 2012; 29(5):656-7. PubMed ID: 22276661
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.
Wang R; Li J; Wang M; Hao H; Chen X; Li R; Zhu X
Br J Dermatol; 2015 Apr; 172(4):968-75. PubMed ID: 25388377
[TBL] [Abstract][Full Text] [Related]
17. Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti-CASPR2 antibodies.
Ong E; Viaccoz A; Ducray F; Pérol M; Cavillon G; Rogemond V; Honnorat J; Petiot P
Eur J Neurol; 2013 Jul; 20(7):e96-7. PubMed ID: 23750840
[No Abstract] [Full Text] [Related]
18. Making sense of antigens and antibodies in pemphigus.
Anhalt GJ
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):763-6. PubMed ID: 10321608
[No Abstract] [Full Text] [Related]
19. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know].
Ingen-Housz-Oro S; Hüe S; Grootenboer-Mignot S; André C
Ann Dermatol Venereol; 2013; 140(8-9):563-70. PubMed ID: 24034645
[No Abstract] [Full Text] [Related]
20. Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults.
Ouedraogo E; Gottlieb J; de Masson A; Lepelletier C; Jachiet M; Salle de Chou C; Galicier L; Bagot M; Chevret S; Bouaziz JD
J Am Acad Dermatol; 2019 Jun; 80(6):1544-1549. PubMed ID: 30981429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]